These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 27827293
1. Vitamin D deficiency, behavioral atypicality, anxiety and depression in children with chromosome 22q11.2 deletion syndrome. Kelley L, Sanders AF, Beaton EA. J Dev Orig Health Dis; 2016 Dec; 7(6):616-625. PubMed ID: 27827293 [Abstract] [Full Text] [Related]
2. Identifying patterns of anxiety and depression in children with chromosome 22q11.2 deletion syndrome: comorbidity predicts behavioral difficulties and impaired functional communications. Stephenson DD, Beaton EA, Weems CF, Angkustsiri K, Simon TJ. Behav Brain Res; 2015 Jan 01; 276():190-8. PubMed ID: 24906195 [Abstract] [Full Text] [Related]
3. An examination of the relationship of anxiety and intelligence to adaptive functioning in children with chromosome 22q11.2 deletion syndrome. Angkustsiri K, Leckliter I, Tartaglia N, Beaton EA, Enriquez J, Simon TJ. J Dev Behav Pediatr; 2012 Jan 01; 33(9):713-20. PubMed ID: 23117596 [Abstract] [Full Text] [Related]
4. Working Memory Impairments in Chromosome 22q11.2 Deletion Syndrome: The Roles of Anxiety and Stress Physiology. Sanders AF, Hobbs DA, Stephenson DD, Laird RD, Beaton EA. J Autism Dev Disord; 2017 Apr 01; 47(4):992-1005. PubMed ID: 28083777 [Abstract] [Full Text] [Related]
5. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome]. Demily C, Rossi M, Schneider M, Edery P, Leleu A, d'Amato T, Franck N, Eliez S. Encephale; 2015 Jun 01; 41(3):266-73. PubMed ID: 25523123 [Abstract] [Full Text] [Related]
6. Developmental trajectories in 22q11.2 deletion. Swillen A, McDonald-McGinn D. Am J Med Genet C Semin Med Genet; 2015 Jun 01; 169(2):172-81. PubMed ID: 25989227 [Abstract] [Full Text] [Related]
7. The hippocampi of children with chromosome 22q11.2 deletion syndrome have localized anterior alterations that predict severity of anxiety. Scott JA, Goodrich-Hunsaker N, Kalish K, Lee A, Hunsaker MR, Schumann CM, Carmichael OT, Simon TJ. J Psychiatry Neurosci; 2016 Apr 01; 41(3):203-13. PubMed ID: 26599134 [Abstract] [Full Text] [Related]
8. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study. Gothelf D, Schneider M, Green T, Debbané M, Frisch A, Glaser B, Zilkha H, Schaer M, Weizman A, Eliez S. J Am Acad Child Adolesc Psychiatry; 2013 Nov 01; 52(11):1192-1203.e3. PubMed ID: 24157393 [Abstract] [Full Text] [Related]
9. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome. Niarchou M, Calkins ME, Moore TM, Tang SX, McDonald-McGinn DM, Zackai EH, Emanuel BS, Gur RC, Gur RE. Schizophr Bull; 2018 Jun 06; 44(4):824-833. PubMed ID: 29040797 [Abstract] [Full Text] [Related]
10. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome. Niarchou M, Moore TM, Tang SX, Calkins ME, McDonald-McGuinn DM, Zackai EH, Emanuel BS, Gur RC, Gur RE. J Psychiatr Res; 2017 Sep 06; 92():124-131. PubMed ID: 28433949 [Abstract] [Full Text] [Related]
11. 22q11.2 duplication syndrome: elevated rate of autism spectrum disorder and need for medical screening. Wenger TL, Miller JS, DePolo LM, de Marchena AB, Clements CC, Emanuel BS, Zackai EH, McDonald-McGinn DM, Schultz RT. Mol Autism; 2016 Sep 06; 7():27. PubMed ID: 27158440 [Abstract] [Full Text] [Related]
12. The Effectiveness and Safety of Antipsychotic and Antidepressant Medications in Individuals with 22q11.2 Deletion Syndrome. Dori N, Green T, Weizman A, Gothelf D. J Child Adolesc Psychopharmacol; 2017 Feb 06; 27(1):83-90. PubMed ID: 26131914 [Abstract] [Full Text] [Related]
13. Developmental coordination disorder, psychopathology and IQ in 22q11.2 deletion syndrome. Cunningham AC, Delport S, Cumines W, Busse M, Linden DEJ, Hall J, Owen MJ, van den Bree MBM. Br J Psychiatry; 2018 Jan 06; 212(1):27-33. PubMed ID: 29433607 [Abstract] [Full Text] [Related]
14. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes. Parker DA, Cubells JF, Imes SL, Ruban GA, Henshey BT, Massa NM, Walker EF, Duncan EJ, Ousley OY. BMC Psychiatry; 2023 Jun 13; 23(1):425. PubMed ID: 37312091 [Abstract] [Full Text] [Related]
15. Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia? Demily C, Franck N. Eur J Med Genet; 2016 Nov 13; 59(11):596-603. PubMed ID: 27639442 [Abstract] [Full Text] [Related]
16. Craniofacial dysmorphology in 22q11.2 deletion syndrome by 3D laser surface imaging and geometric morphometrics: illuminating the developmental relationship to risk for psychosis. Prasad S, Katina S, Hennessy RJ, Murphy KC, Bowman AW, Waddington JL. Am J Med Genet A; 2015 Mar 13; 167A(3):529-36. PubMed ID: 25691406 [Abstract] [Full Text] [Related]
17. Childhood Predictors of Young Adult Social Functioning in 22q11.2 Deletion Syndrome. Wagner KE, Kates WR, Fremont W, Antshel KM. J Autism Dev Disord; 2017 Aug 13; 47(8):2480-2501. PubMed ID: 28527096 [Abstract] [Full Text] [Related]
18. Vitamin D status and the immune assessment in 22q11.2 deletion syndrome. Legitimo A, Bertini V, Costagliola G, Baroncelli GI, Morganti R, Valetto A, Consolini R. Clin Exp Immunol; 2020 Jun 13; 200(3):272-286. PubMed ID: 32149392 [Abstract] [Full Text] [Related]
19. High prevalence of fatigue in adults with a 22q11.2 deletion syndrome. Vergaelen E, Claes S, Kempke S, Swillen A. Am J Med Genet A; 2017 Apr 13; 173(4):858-867. PubMed ID: 28190295 [Abstract] [Full Text] [Related]
20. Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study. Gothelf D, Penniman L, Gu E, Eliez S, Reiss AL. Schizophr Res; 2007 Nov 13; 96(1-3):72-81. PubMed ID: 17804201 [Abstract] [Full Text] [Related] Page: [Next] [New Search]